Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Dolphin Medical Services Ltd. is significantly underperforming compared to its peers in terms of profitability, growth, and valuation, making it a sector laggard. The company's negative metrics across multiple financial categories highlight its struggles, while several peers show strong growth and profitability, indicating a stark contrast in performance within the hospital and healthcare services sector.
Highest revenue growth (YoY: 18.49%) and strong profitability metrics (ROE: 13.47%).
Strong EPS growth (EPS: 100.56) and robust ROE (20.51%), making it a leader in profitability.
Solid revenue growth (YoY: 21.56%) and good profitability (ROE: 15.31%).